MKI67 and glioblastoma: Moreover, considering the low expression of the Ki67 marker in SP-treated mice, the next results demonstrated a higher proliferation index (Ki67 immunopositivity) of GBM tissue from mice co-treated with GW9662 and SP that was similar to that of the control.